Diana Jalal, MD
Enriched profileClinical Associate Professor of Internal Medicine and Deputy Chief of Medicine, VA · University of Iowa
Diana Jalal is Clinical Associate Professor of Internal Medicine and Deputy Chief of Medicine, VA at University of Iowa. OpenAlex indexes 230 publications with 5,952 citations (h-index 38); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.
Data verified 14 Oct 2026
Overview
Updated 14 Oct 2026
Diana Jalal, MD, is Clinical Associate Professor of Internal Medicine and Deputy Chief of Medicine, VA at University of Iowa. The public record shows 230 publications with 5,952 citations (h-index 38), centered on Chronic Kidney Disease and Diabetes, Acute Kidney Injury Research, Blood Pressure and Hypertension Studies. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 3 companies, 3 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · American journal of physiology. Heart and circulatory physiology
- Top research focus: Chronic Kidney Disease and Diabetes
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 78.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Metformin and Vascular Function in Prediabetes
Sponsor: Diana Jalal
- Patient-driven Management of BP in CKD
Sponsor: VA Office of Research and Development
Industry payments
Updated 14 Oct 2026
3 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20241 payment
- ABIOMEDProgram year20241 payment
- CSL BehringProgram year20211 payment
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
59.4%Vitamin D3 Analog59.4%Calcitriol100%Part D<11 patientsCardiovascular
40.6%ACE inhibitor40.6%Lisinopril100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
3 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD
University of Iowa
FY2026$573,080R01DK133240 - Pharmacist-guided, patient-driven management of high blood pressure in CKD: A Novel Approach
Iowa City Va Medical Center
FY2026I01HX003533 - The Alternative Pathway of Complement: A Potential Contributor to Adverse Outcomes in CKD
University of Iowa
FY2025$640,948R01DK133240
Congress activity
Updated 14 Oct 2026
2 congress contributions (2023) across ENDO per OpenAlex. The most recent:
- THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
ENDO Annual Meeting
ENDO2023Co-author - THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
ENDO Annual Meeting
ENDO2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Local endothelin-1 receptor type A antagonism improves cutaneous microvascular function in women with a history of gestational diabetes mellitus.
American journal of physiology. Heart and circulatory physiology
Article2026 - Optimizing Hypertension Control in CKD Through Collaborative Pharmacist Interventions.
Clinical journal of the American Society of Nephrology
Article2026 - Local apocynin improves acetylcholine- but not insulin-mediated vasodilation in the cutaneous microvasculature of women with a history of gestational diabetes.
Journal of applied physiology (Bethesda, Md.
Article2026
Most-cited works
by citation count (OpenAlex)- 01Uric acid and chronic kidney disease: which is chasing which?Article654 citations2013
- 02Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and TreatmentArticle334 citations2020
- 03Uric Acid as a Target of Therapy in CKDArticle269 citations2012
- 04Disorders of Hemostasis Associated with Chronic Kidney DiseaseArticle231 citations2010
- 05Increased Fructose Associates with Elevated Blood PressureArticle203 citations2010
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Pubmed.ncbi.nlm.nih.gov
Research focus in chronic kidney disease and nephrology with 77+ publications
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pubmed.ncbi.nlm.nih.gov ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MBBS
University of Jordan
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Internal Medicine Residency
University of Iowa
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Nephrology Fellowship
Baylor College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →internalmedicineiowa.org ↗ - Research Fellowship
University of Texas at Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cms.gov ↗
Editorial & leadership roles
journal and society appointments- Editorial Board Member
Advances in Chronic Kidney Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Editorial Board Member
Clinical Journal of the American Society of Nephrology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Member
American Heart Association Leadership Committee for the Council on the Kidney in Cardiovascular Disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗
Awards & honors
honors on the public record- NIH National Heart
Lung, and Blood Institute (NHLBI) R01 Grant, four-year $2.3 million award for curcumin supplementation research in chronic kidney disease
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Director
CADRE (Center of Innovation), Iowa City VA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Associate Professor of Medicine (previous)
University of Colorado Denver
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗ - Clinical Director for Renal (previous)
University of Colorado Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →internalmedicineiowa.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Hunsicker, MD
University of Iowa
Brian Olshansky, MD
University of Iowa
Robert Weiss, MD
University of Iowa
Elliott Sohn, MD
University of Iowa
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)